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Introduction
An emerging clinical role for community pharmacists is to become actively
involved in the follow-up care of patients who are discharged back into the
community (transfer of care services) by promoting better medication adherence
and by contributing to the safe, effective, and efﬁcient use of medication.1 Recent
research highlights how this extended role of community pharmacists could help to
reduce drug-related adverse events, unnecessary health provider visits, hospitaliza-
tions, and readmissions while strengthening integrated primary care delivery across
the healthcare system.1,2
Risk prediction models have been developed to effectively target the offering of
postdischarge interventions to reduce patient hospital readmission. These tools aim
to standardize the offer and provision of services that could otherwise be dependent
upon professional and clinical expertise, knowledge and bias. Despite over 30 years
of work to develop and optimize a risk prediction tool, there is limited consensus on
the fundamental patient parameters that are most useful to target delivery of read-
mission-reducing interventions.3–5
A consensus methodological approach was adopted in this study to address
a gap in the literature by identifying appropriate referral criteria of hospital inpa-
tients for follow-up care in the primary care setting.
Methods
Phase 1
Semistructured interviews were conducted in February 2018 with a small number
(n=4) of experts purposively sampled due to their involvement in delivering,
designing or managing transfer of care services between hospital and community
pharmacy. The interviewer probed about potential referral criteria for patients to be
offered postdischarge care. Transcribed interview data were analyzed using
inductive thematic analysis to generate category systems and repeated themes.6
Phase 2
The stakeholder interviews informed the design of a survey tool to be employed
in an adapted two-round Delphi consensus activity.7 The survey was reviewed
and piloted by two clinical pharmacists for clarity of language and face validity.
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The Delphi panel members included senior pharmacists,
pharmacy directors and managers across the primary and
secondary care sectors nationwide whom were known to
the study team members and who are involved in the
design, delivery and management of transfer of care
services. These individuals were recruited through
a combination of convenience and snowball sampling.
Participants were asked to indicate which patient char-
acteristics were important to consider when deciding
whether to offer postdischarge care, and then asked to
rank these identiﬁed characteristics by level of importance
(1=not important, 10=very important). Based on the ﬁrst
round of responses, a reﬁned survey was sent out again to
the same stakeholders to validate the patient referral
criteria.
Favourable ethical approval was granted by the Faculty
of Medical Sciences, Newcastle University.
Results
The early interviews offered a range of factors to be considered
when determining whether an inpatient should be referred to
their community pharmacist upon discharge for follow-up
care.
Of 29 invited panellists, 10 consented to take part. The
participants represented primary (n=2) and secondary care
settings (n=7), and represented the North East (n=2), the
South (n=4), the North West (n=2), and the South East
(n=2) regions of England. All 10 participants completed all
questions giving a response rate at round 1 of 34%. These 10
participants also completed round 2 of the Delphi. Table 1
shows whether the participants thought the patient character-
istics were important or not and their relative ranking of
importance. Round 2 results are also displayed where 3 out
of 5 factors achieved a high level of consensus (≥90%).
Discussion
This study presents that consensus was achieved across
three inpatient referral criteria:
1. Changed medication as inpatient
2. New medication on discharge
3. High-risk drugs
This work offers service designers, providers and managers
some guidance on inpatients who may be appropriate to refer
through transfer of care, or postdischarge services.
Table 1 The inpatient referral criteria identiﬁed through semistructured interviews, indication of importance and relative importance
in Round 1, and validated indication of importance in Round 2 of the Delphi consensus
Identiﬁed inpatient criteria Round 1 Round 2
Patient factors that could deter-
mine appropriate referral criteria
Indicated as important
(number of participants)
Relative impor-
tance (%)*
Indicated as important
(number of participants)
Patient demographics
Age 8 38 0
Residential status 8 24 0
Deprivation index 4 12 0
Health/illness status
Diagnosed condition 9 32 0
Presence of comorbidities 9 40 4
Medication factors
High-risk drugs (NPSA** classiﬁcation) 10 73 9
Polypharmacy 10 68 6
Changes in medication during inpatient stay 10 81 10
New medication on discharge 10 75 10
Health care use
Number of previous admissions 8 36
Notes: *Calculated by
Total sum of the ranking scores across the 10 participants
Highest total sum of the ranking scores ð100Þ  100. **National Patient Safety Agency, England.
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This study is based on expert opinion of a small number
of panellists self-selecting from practice who have a keen
interest in transfer of care services. These factors limit the
ﬁndings as a larger sample size from a wider population
would improve overall reliability.
Further research is also required to explore the feasi-
bility of adopting this referral criteria and empirically
assessing if patients ﬁtting this criteria beneﬁt most from
postdischarge care from community pharmacists.
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